Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
115,000
Employees115,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
115,000
Employees115,000

ABT Key Statistics

Market cap
196.07B
Market cap196.07B
Price-Earnings ratio
33.31
Price-Earnings ratio33.31
Dividend yield
2.37%
Dividend yield2.37%
Average volume
12.11M
Average volume12.11M
High today
$107.32
High today$107.32
Low today
$104.48
Low today$104.48
Open price
$105.17
Open price$105.17
Volume
8.16M
Volume8.16M
52 Week high
$137.49
52 Week high$137.49
52 Week low
$81.97
52 Week low$81.97

Stock Snapshot

As of today, Abbott(ABT) shares are valued at $105.77. The company's market cap stands at 196.07B, with a P/E ratio of 33.31 and a dividend yield of 2.37%.

During the trading session on 2026-07-31, Abbott(ABT) shares reached a daily high of $107.32 and a low of $104.48. At a current price of $105.77, the stock is +1.2% higher than the low and still -1.4% under the high.

Trading activity shows a volume of 8.16M, compared to an average daily volume of 12.11M.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.

Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.

ABT News

MarketWatch 11h
Abbott Laboratories stock outperforms competitors despite losses on the day - marketwatch.com

...

Abbott Laboratories stock outperforms competitors despite losses on the day - marketwatch.com
Simply Wall St 18h
Why Abbott Is Up 7.4% After Mixed Q2 Results And Expanded Heart Device, Diagnostics Push

Abbott Laboratories recently reported second-quarter 2026 results showing sales rising to US$12,593 million from US$11,142 million a year earlier, while net inc...

Why Abbott Is Up 7.4% After Mixed Q2 Results And Expanded Heart Device, Diagnostics Push
Simply Wall St 2d
Abbott Lands Exclusive Rights To FDA Approved SimpleScreen In The U.S.

FDA has approved Freenome's SimpleScreen blood-based colorectal cancer test for average-risk adults. Abbott Laboratories, NYSE:ABT, holds exclusive rights to c...

Abbott Lands Exclusive Rights To FDA Approved SimpleScreen In The U.S.

Analyst ratings

78%

of 27 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

More ABT News

TipRanks 2d
Abbott Laboratories: Buy Rating Backed by Strengthening Nutrition Franchise and 2026 Growth Drivers

In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on Abbott Laboratories, with a price target of $115.00. Claim 55% Off TipRan...

Nasdaq 2d
These 3 Companies Reported Record Results and Raised Guidance

The 2026 Q2 earnings cycle continues to roll along, with the reporting docket remaining stacked in the coming days and weeks. The period has been another one of...

These 3 Companies Reported Record Results and Raised Guidance
TipRanks 4d
Freenome, Abbott announce FDA approval of SimpleScreen CRC

Freenome (FRNM) and Abbott (ABT) announced that the FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in adults 45 and...

TipRanks 6d
Schwab US Dividend Equity ETF Sees Strong Inflows

Schwab US Dividend Equity ETF ( $SCHD ) has risen by 1.65% in the past week. It has experienced a 5-day net inflow of $682.61 million. This is due, in part, to...

Simply Wall St 6d
Abbott Laboratories Could Be 14% Undervalued On Mixed Earnings And Growth Focus

Abbott Laboratories (ABT) is back on investors’ radar after second quarter 2026 earnings showed higher year over year sales alongside lower net income and earni...

Abbott Laboratories Could Be 14% Undervalued On Mixed Earnings And Growth Focus

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.